Use of rituximab in the treatment of Epstein-Barr virus reactivation after allogeneic stem cell transplantation: a retrospective study in 86 patients

被引：0
|
作者：
Auger, S. [1 ]
Mines, M. L. [1 ]
Fegueux, N. [1 ]
Ceballos, P. [1 ]
Segondy, M. [1 ]
Rossi, J. -F. [1 ]
机构：
[1] St Eloi Univ Hosp, Montpellier, France
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 50 条
  • [21] Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation
    Zhou, Jing-Rui
    Shi, Da-Yu
    Wei, Rong
    Wang, Yu
    Yan, Chen-Hua
    Zhang, Xiao-Hui
    Xu, Lan-Ping
    Liu, Kai-Yan
    Huang, Xiao-Jun
    Sun, Yu-Qian
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [22] Features of Epstein-Barr Virus (EBV) reactivation after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation
    Peric, Z.
    Cahu, X.
    Chevallier, P.
    Brissot, E.
    Malard, F.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Dubruille, V.
    Le Gouill, S.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Saulquin, B.
    Harousseau, J-L
    Moreau, P.
    Milpied, N.
    Coste-Burel, M.
    Imbert-Marcille, B-M
    Mohty, M.
    LEUKEMIA, 2011, 25 (06) : 932 - 938
  • [23] Guillain-Barre sindrome within Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation
    Baldini, S.
    Nozzoli, C.
    Gozzini, A.
    Bartolozzi, B.
    Guidi, S.
    Bosi, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S215 - S216
  • [24] Weekly Low-Dose Rituximab As the Preemptive Management of Epstein-Barr Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Novel Strategy?
    Chen, Feng
    Depei, Wu
    Tao, Tao
    Gong, Wei
    Ye, Chunmei
    Tang, XiaoWen
    Han, Yue
    Qiu, Huiying
    BLOOD, 2015, 126 (23)
  • [25] Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation
    Burns, David
    Rana, Shabeeha
    Howman, Andrew
    Nagra, Sandeep
    Ward, Janice
    Osman, Husam
    Taha, Yusri
    Byrne, Jenny
    Das-Gupta, Emma
    Raghavan, Manoj
    Malladi, Ram
    Cook, Mark
    Mahendra, Prem
    Russell, Nigel H.
    Craddock, Charles
    Fox, Christopher
    Chaganti, Sridhar
    BLOOD, 2012, 120 (21)
  • [26] The efficacy and safety of rituximab in treatment of Epstein-Barr virus disease post allogeneic hematopoietic stem-cell transplantation
    许兰平
    ChinaMedicalAbstracts(InternalMedicine), 2013, 30 (01) : 58 - 58
  • [27] Use of Rituximab As a Pre-Emptive Therapy for Epstein-Barr Virus (EBV)-Associated Lymphoproliferative Disorders in 86 Adult Patients Having Allogeneic Stem Cell Transplantation
    Auger, Sophie
    Orsini, Mattea
    Fegueux, Nathalie
    Ceballos, Patrice
    Mines, Marie Luce
    Rossi, Jean-Francois
    BLOOD, 2011, 118 (21) : 871 - 871
  • [28] Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation
    Ahmad, Imran
    Cau, Nguyen V.
    Kwan, John
    Maaroufi, Younes
    Meuleman, Nathalie
    Aoun, Mickael
    Lewalle, Philippe
    Martiat, Philippe
    Crokaert, Francoise
    Bron, Dominique
    TRANSPLANTATION, 2009, 87 (08) : 1240 - 1245
  • [29] Rituximab Treatment for Epstein-Barr Virus DNAemia after Alternative-Donor Hematopoietic Stem Cell Transplantation
    Coppoletta, Stefania
    Tedone, Elisabetta
    Galano, Barbara
    Soracco, Monica
    Raiola, Anna Maria
    Lamparelli, Teresa
    Gualandi, Francesca
    Bregante, Stefania
    Ibatici, Adalberto
    di Grazia, Carmen
    Dominietto, Alida
    Varaldo, Riccardo
    Bruno, Barbara
    Frassoni, Francesco
    Van Lint, Maria Teresa
    Bacigalupo, Andrea
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (06) : 901 - 907
  • [30] Controlled Epstein-Barr virus reactivation after allogeneic transplantation is associated with improved survival
    Auger, Sophie
    Orsini, Mattea
    Ceballos, Patrice
    Fegueux, Nathalie
    Kanouni, Tarik
    Caumes, Bastien
    Klein, Bernard
    Villalba, Martin
    Rossi, Jean-Francois
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2014, 92 (05) : 421 - 428
12345